{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "339",
                "349"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "cefazolina"
        },
        {
            "identifier": "T2",
            "position": [
                "351",
                "358"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "fragmin"
        },
        {
            "identifier": "T3",
            "position": [
                "360",
                "363"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "ANA"
        },
        {
            "identifier": "T4",
            "position": [
                "603",
                "683"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 izolowanego prze\u0142o\u017cenia wielkich pni t\u0119tniczych"
        },
        {},
        {
            "identifier": "T5",
            "position": [
                "685",
                "719"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Z\u0142o\u017cona anomalia t\u0119tnic wie\u0144cowych"
        },
        {
            "identifier": "T6",
            "position": [
                "729",
                "750"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "korekcji anatomicznej"
        },
        {
            "identifier": "T7",
            "position": [
                "751",
                "773"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "w okresie noworodkowym"
        },
        {
            "identifier": "T8",
            "position": [
                "775",
                "786"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "29.04.2009r"
        },
        {
            "identifier": "T9",
            "position": [
                "929",
                "948"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {
            "identifier": "T10",
            "position": [
                "1025",
                "1035"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan dobry"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T4",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N2",
            "referenced": "T6",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N3",
            "referenced": "T9",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 9 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\ncefazolina, fragmin, ANA\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: ICD10:Q20.3|Rozpoznanie II: ICD10:Z98.8|Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 izolowanego prze\u0142o\u017cenia wielkich pni t\u0119tniczych. Z\u0142o\u017cona anomalia t\u0119tnic wie\u0144cowych. Stan po korekcji anatomicznej w okresie noworodkowym (29.04.2009r). \\x0a\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opiec z wrodzon\u0105 wad\u0105 serca przyj\u0119ty do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nPotas: K:4.00[mmol/L]\nS\u00f3d: Na:142.00[mmol/L]\nMorfologia\n    WBC:7.52[10\\\\^3/ul]\n    RBC:4.57[10\\\\^6/ul]\n    HGB:13.3[g/dl]\n    HCT:36.8[%]\n    MCV:80.5[fl]\n    MCH:29.1[pg]\n    MCHC:36.1[g/dl]\n    PLT:231.0[10\\\\^3/ul]\n    RDW-SD:36.2[fl]\n    RDW-CV:12.6[%]\n    PDW:15.0[fl]\n    MPV:11.8[fl]\n    P-LCR:39.2[%]\n    PCT:0.3[%]\n    NEUTR#:4.13[10\\\\^3/ul]\n    NEUTR%:54.9[%]\n    LYMPH#:2.15[10\\\\^3/ul]\n    LYMPH%:28.6[%]\n    MONO#:0.70[10\\\\^3/ul]\n    MONO%:9.30[%]\n    EO#:0.51[10\\\\^3/ul]\n    EO%:6.80[%]\n    BASO#:0.03[10\\\\^3/ul]\n    BASO%:0.40[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nImmununochemia -Immulite: COMMENT_HL7:\nProkalcytonina (PCT): PROKAL:0.06[ng/ml]\nD-dimery t. ilo\u015bciowy: D-dimer:145.0[ng/ml]\nFibrynogen (F): FIB:2.39[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:31.1[s]\nINR: INR:1.1\nCzas protrombinowy (PT): PT:12.0[s]\nCzas trombinowy (TT): TT:15.7[s]\nChlorki: Cl:102.00[mmol/L]\nWap\u0144 ca\u0142kowity: Ca:2.53[mmol/L]\nCK - kinaza kreatynowa: CK:166.00[IU/L]\nMagnez: Mg:0.78[mmol/L]\nGGTP gammaglutamylotranspeptydaza: GGT:13.00[IU/L]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:92[%]\nKreatynina: CREA:0.60[mg/dl]\nMocznik: UREA:39.00[mg/dl]\nASPAT: AST:32.00[IU/L]\nALAT: ALT:29.00[IU/L]\nNT- proBNP: NTpBNP:26.40[pg/ml]\nTroponina T\n    TnT hs:\n    3.00[pg/ml]\nCK-MB aktywno\u015b\u0107: CK-MBakt.:49.00[IU/L]\nGlukoza w surowicy: GLU-sur:111[mg/dl]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:90.2[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:131[cm]\neGFR (1-13r\u017c M) stand.wg.Schwartza  wsp. 0.550: eGFR 1-13M:120.1[ml/min/1,73m2]\nImmunochemia - parametry krytyczne: COMMENT_HL7:\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    NR-KS:K18/000100\n    DONACJA:Z511518000027\n------------------------------------------------\nICD10\n------------------------------------------------\nQ20.3\nZ98.8\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n37.21\n88.721\n100.12\n89.541\n------------------------------------------------"
}